
    
      Nine months multi-center prospective, randomized observational study, two arm trial to
      evaluate the effect of MBDA score-guided care on disease activity and medical costs. To
      investigate whether treatment decisions guided by MBDA scores result in reduced disease
      activity and overall medical cost among patients with RA relative to usual care (UC).
    
  